Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Aptol Pharma ApS
APS
Bankrupt
Advertising protection
CVR 39308967
Thad Jones Vej 6, 2450
København SV
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
1 employees
aptolpharma.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Aptol Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KG
Kira Gerber Astakhova
Founder
Founder
2018
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
AD
Anders Dyhr Dombernowsky-Toft
Chairman
Chairman
2023 – 2025
MH
Mads Hartvig Clausen
Chairman
Chairman
2025 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
KGAA Holding ApS
Company
33.33–49.99%
33.33–49.99%
2025
MDZ Solutions OÜ
Individual
15–19.99%
15–19.99%
2025
Tue Wenzel Kragstrup
Individual
15–19.99%
15–19.99%
2025
Peter Andreas Nicolai Reumert Wagtmann
Individual
10–14.99%
10–14.99%
2025
ADT HOLDING ApS
Company
10–14.99%
10–14.99%
2025
2200 HOLDING ApS
Company
15–19.99%
15–19.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Aptol Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
